Indeed, in the case of type 1 diabetic (T1D) mice, where islet β cells were destroyed using streptozotocin (STZ) (Fig. 3f), the administration of apoA-IV did not lead to improved glucose tolerance (Fig. 3g). Here, APOA4 is linked to type 1 diabetes mellitus.